Health Results-Based Financing Impact Evaluation 2013, Health Facility Baseline Survey
Burkina Faso, 2013 - 2014
Get Microdata
Reference ID
BFA_2013_HRBFIE-FBL_v01_M
Producer(s)
Paul Jacob Robyn, Aurelia Souares, Herve Hien
Collection(s)
Metadata
Created on
Jan 13, 2017
Last modified
Jan 17, 2017
Page views
137891
Downloads
9907
F7_219_Médicament donné 1 (f7_219_1)
Data file: f7_aug19
Overview
Valid:
21
Invalid:
0
Type:
Discrete
Start:
802
End:
827
Width:
26
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0,40 | 1 |
4.8%
|
|
| 2 CP DE IBUPROFEN | 1 |
4.8%
|
|
| ACT | 1 |
4.8%
|
|
| ALBENDAZOLE 100MG COMPRIME | 1 |
4.8%
|
|
| AMOXICILLINE (4PLAQUETTES) | 1 |
4.8%
|
|
| ASL 900MG | 1 |
4.8%
|
|
| BUTYL COMPRIME | 1 |
4.8%
|
|
| ERYTHROMYCINE | 1 |
4.8%
|
|
| FER | 1 |
4.8%
|
|
| FER + ACIDE FOLIQUE | 1 |
4.8%
|
|
| FER ACIDE FOLIC | 1 |
4.8%
|
|
| FUROSEMIDE | 1 |
4.8%
|
|
| METHYLPREDNISOLONE | 1 |
4.8%
|
|
| METRO | 1 |
4.8%
|
|
| OCYTOCINE | 2 |
9.5%
|
|
| PARA | 1 |
4.8%
|
|
| PHILCO-CAPTO 25 | 1 |
4.8%
|
|
| RINGER LACTATE | 1 |
4.8%
|
|
| VITAMINE A | 2 |
9.5%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.